Filing Flows › Gossamer Bio (GOSS) › Q1 2026 › vs Q4 2025
Gossamer Bio (GOSS) Q1 2026 vs Q4 2025 (quarter over quarter)
Gossamer Bio's revenue rose $3.2M (+23%) from $13.8M in Q4 2025 to $17.0M in Q1 2026.
Gossamer Bio, Q1 2026: revenue $17.0M (+72% year over year), operating margin -264.6%, net loss $46.7M, operating cash flow −$38.7M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $17.0M | $13.8M | $3.2M | +23% |
| Net loss | $46.7M | $47.2M | −$574K | -1% |
| Costs & expenses | $63.6M | $61.1M | $2.5M | +4% |
| Operating costs | $61.8M | $59.8M | $2.0M | +3% |
| Interest & other, net | $1.8M | $1.3M | $511K | +40% |
| Research & development | $43.1M | $48.9M | −$5.9M | -12% |
| General & admin | $18.7M | $10.9M | $7.8M | +72% |
| Operating cash sources | $46.7M | $47.2M | −$574K | -1% |
| Depreciation & amortization | $5K | $6K | −$1K | -17% |
| Share-based compensation | $6.3M | $2.9M | $3.4M | +118% |
| Working capital & other | $1.6M | −$4.0M | $5.6M | — |
| Cash used in operations | $38.7M | $48.3M | −$9.6M | -20% |
| Net loss absorbed | $46.7M | $47.2M | −$574K | -1% |
Questions
How much did Gossamer Bio's revenue grow quarter over quarter in Q1 2026?
Gossamer Bio's revenue rose $3.2M (+23%) from $13.8M in Q4 2025 to $17.0M in Q1 2026.